Bio-Gene Technology Limited BGT.AX Stock
Bio-Gene Technology Limited Price Chart
Bio-Gene Technology Limited BGT.AX Financial and Trading Overview
| Bio-Gene Technology Limited stock price | 0.07 AUD |
| Previous Close | 0.09 AUD |
| Open | 0.09 AUD |
| Bid | 0.08 AUD x 0 |
| Ask | 0.1 AUD x 0 |
| Day's Range | 0.09 - 0.09 AUD |
| 52 Week Range | 0.07 - 0.16 AUD |
| Volume | 392.82K AUD |
| Avg. Volume | 84.56K AUD |
| Market Cap | 15.66M AUD |
| Beta (5Y Monthly) | 0.473563 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BGT.AX Valuation Measures
| Enterprise Value | 11.4M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 161.93849 |
| Price/Book (mrq) | 3.6666665 |
| Enterprise Value/Revenue | 117.913 |
| Enterprise Value/EBITDA | -3.276 |
Trading Information
Bio-Gene Technology Limited Stock Price History
| Beta (5Y Monthly) | 0.473563 |
| 52-Week Change | -34.81% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.16 AUD |
| 52 Week Low | 0.07 AUD |
| 50-Day Moving Average | 0.1 AUD |
| 200-Day Moving Average | 0.1 AUD |
BGT.AX Share Statistics
| Avg. Volume (3 month) | 84.56K AUD |
| Avg. Daily Volume (10-Days) | 57.4K AUD |
| Shares Outstanding | 177.91M |
| Float | 114.68M |
| Short Ratio | N/A |
| % Held by Insiders | 34.97% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3646.38% |
| Gross Margin | -179.35% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -36.14% |
| Return on Equity (ttm) | -66.35% |
Income Statement
| Revenue (ttm) | 96.68K AUD |
| Revenue Per Share (ttm) | 0.001 AUD |
| Quarterly Revenue Growth (yoy) | -81.00000000000000000000000000000000% |
| Gross Profit (ttm) | 222.1K AUD |
| EBITDA | -3479989 AUD |
| Net Income Avi to Common (ttm) | -3447382 AUD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.26M AUD |
| Total Cash Per Share (mrq) | 0.02 AUD |
| Total Debt (mrq) | 0 AUD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 5.604 |
| Book Value Per Share (mrq) | 0.024 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3016551 AUD |
| Levered Free Cash Flow (ttm) | -1667411 AUD |
Profile of Bio-Gene Technology Limited
| Country | Australia |
| State | VIC |
| City | Melbourne |
| Address | 456 Lonsdale Street |
| ZIP | 3000 |
| Phone | 61 3 9068 1062 |
| Website | https://www.bio-gene.com.au |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Bio-Gene Technology Limited, an agtech development company, engages in developing and commercializing insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. Its lead products include Flavocide, a beta-triketone insecticide product; and Qcide, a natural oil extracted from a cultivar of eucalyptus cloeziana. The company has a research collaboration agreement with James Cook University for the development of a tissue culture system to support the expansion of tree plantations and scale-up of future Qcide oil production. It also has research collaborations with BASF, Grains Research and Development Corporation, and Queensland Department of Agriculture and Fisheries for assessing activity against grain storage pests. Bio-Gene Technology Limited was incorporated in 1995 and is based in Melbourne, Australia.
Q&A For Bio-Gene Technology Limited Stock
What is a current BGT.AX stock price?
Bio-Gene Technology Limited BGT.AX stock price today per share is 0.07 AUD.
How to purchase Bio-Gene Technology Limited stock?
You can buy BGT.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bio-Gene Technology Limited?
The stock symbol or ticker of Bio-Gene Technology Limited is BGT.AX.
Which industry does the Bio-Gene Technology Limited company belong to?
The Bio-Gene Technology Limited industry is Biotechnology.
How many shares does Bio-Gene Technology Limited have in circulation?
The max supply of Bio-Gene Technology Limited shares is 201.36M.
What is Bio-Gene Technology Limited Price to Earnings Ratio (PE Ratio)?
Bio-Gene Technology Limited PE Ratio is now.
What was Bio-Gene Technology Limited earnings per share over the trailing 12 months (TTM)?
Bio-Gene Technology Limited EPS is -0.02 AUD over the trailing 12 months.
Which sector does the Bio-Gene Technology Limited company belong to?
The Bio-Gene Technology Limited sector is Healthcare.